NL
EW icon

NVWM LLC’s Edwards Lifesciences EW Stock Holding History

NVWM LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
17,937
+165
+0.9% +$13.8K 0.33% 89
2026
Q1 		$1.42M Buy
17,772
+606
+4% +$50K 0.32% 96
2025
Q4 		$1.46M Buy
17,166
+17,143
+74,535% +$1.41M 0.32% 98
2025
Q3 		$1.79K Hold
23
– – ﹤0.01% 456
2025
Q2 		$1.8K Hold
23
– – ﹤0.01% 438
2025
Q1 		$1.67K Buy
23
+5
+28% +$358 ﹤0.01% 419
2024
Q4 		$1.33K Buy
18
+5
+38% +$350 ﹤0.01% 422
2024
Q3 		$858 Buy
13
+3
+30% +$218 ﹤0.01% 491
2024
Q2 		$924 Sell
10
-1
-9% -$89 ﹤0.01% 453
2024
Q1 		$1.05K Buy
+11
New +$924 ﹤0.01% 397
2023
Q3 		– Sell
-6,347
Closed -$599K – 443
2023
Q2 		$599K Buy
+6,347
New +$552K 0.19% 146
2022
Q4 		– Sell
-6,619
Closed -$547K – 449
2022
Q3 		$547K Hold
6,619
– – 0.22% 135
2022
Q2 		$630K Sell
6,619
-2,450
-27% -$254K 0.24% 135
2022
Q1 		$1.07M Sell
9,069
-90
-1% -$10.1K 0.34% 101
2021
Q4 		$1.19M Buy
9,159
+700
+8% +$81.7K 0.37% 95
2021
Q3 		$958K Sell
8,459
-154
-2% -$17.6K 0.34% 110
2021
Q2 		$892K Sell
8,613
-2
-0% -$189 0.32% 122
2021
Q1 		$721K Buy
8,615
+217
+3% +$18.3K 0.29% 133
2020
Q4 		$766K Buy
8,398
+198
+2% +$16.4K 0.32% 109
2020
Q3 		$654K Sell
8,200
-16
-0.2% -$1.25K 0.31% 105
2020
Q2 		$568K Sell
8,216
-298
-4% -$21.2K 0.31% 105
2020
Q1 		$535K Buy
8,514
+543
+7% +$39.2K 0.37% 80
2019
Q4 		$620K Sell
7,971
-249
-3% -$19.4K 0.37% 87
2019
Q3 		$603K Buy
8,220
+27
+0.3% +$1.9K 0.37% 101
2019
Q2 		$505K Buy
8,193
+3,291
+67% +$199K 0.3% 113
2019
Q1 		$313K Buy
+4,902
New +$280K 0.21% 134

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

NVWM LLC's EW Position: Q2 2026 in Review

NVWM LLC increased its Edwards Lifesciences (EW) stake by 0.93% in Q2 2026, buying an estimated $13.8K and bringing the position to 17,937 shares worth $1.62M. The position accounts for 0.33% of the portfolio, ranked #89.

NVWM LLC first reported a position in EW in Q1 2019 and has held it in 26 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • NVWM LLC held 17,937 shares of Edwards Lifesciences worth $1.62M as of Q2 2026.
  • NVWM LLC bought 165 Edwards Lifesciences shares in Q2 2026, an estimated $13.8K.
  • Edwards Lifesciences made up 0.33% of NVWM LLC's portfolio in Q2 2026, its #89 holding.
  • NVWM LLC first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 26 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.